Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
Top Cited Papers
- 25 April 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (9) , 1496-1502
- https://doi.org/10.1016/s0735-1097(02)01786-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Congenital Heart Disease in AdultsNew England Journal of Medicine, 2000
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Protective Effect of Beraprost Sodium, a Stable Prostacyclin Analogue, in Development of Monocrotaline-Induced Pulmonary HypertensionJournal of Cardiovascular Pharmacology, 1996
- Interactions Between Endothelial MediatorsBasic & Clinical Pharmacology & Toxicology, 1995
- Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.Circulation, 1994
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Decreased Arterial Wall Prostaglandin Production in Neonatal Calves with Severe Chronic Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 1989
- Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.Circulation, 1989
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976